Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Bellerophon Therapeutics Inc. logo

Bellerophon Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

0.05
 
USD
  
0.00
  
(-4.73%)
Optionable: No  Market Cap: 1 M  90-day average vol: 49,297

Previous close: 0.0571  Open: 0.0542  Bid:   Ask:
52 week range    
0.03   
   11.15
Peers   
BAX / 
ABT / 
OPK / 
Last updated: Monday 22nd April 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ABEO

0 B-0.40.2626

ABT

0.0147225 B32.4128.05

BAX

0.012943 B35.986.87

OPK

2 B27.83.26
Financials

BLPH Income Statement

Annual
Invalid dateDec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Basic EPS from continuing operations-2.95-3.17-1.87-2.08
Basic EPS total0.75-2.95-3.17-1.87-2.08
Basic weighted shares outstanding817846.01 M3 M4 M5 M8 M10 M10 M
Depreciation300000.0100000.0100000.0100000.0
DepreciationAndAmortization300000.0100000.0100000.0100000.0
Diluted EPS total-56.85-23.7-21.15-5.1-2.95-3.17-1.87-2.08
Diluted normalized net income/share-2.95-3.17-1.87-2.08
Diluted weighted shares outstanding817220.01 M3 M4 M5 M8 M10 M10 M
GeneralAndAdministrativeExpense15 M7 M7 M8 M6 M8 M7 M6 M
Gross operating profit2 M
Income before tax-46 M-24 M-55 M-3 M-15 M-27 M-20 M-22 M
Income restructuring and M&A352000.0
Income taxes-438000.0-5 M-2 M-2 M-2 M-2 M
Interest income109000.095000.0184000.0378000.0397000.0
MiscOtherSpecialCharges-590000.0-30 M25 M3 M-577000.0605000.0136000.0
Net income from total operations-46 M-24 M-55 M3 M-13 M-25 M-18 M-20 M
NetIncomeCommonStockholders-46 M-24 M-55 M3 M-13 M-25 M-18 M-20 M
NetIncomeContinuousOperations-46 M-24 M-55 M3 M-13 M-25 M-18 M-20 M
NetNonOperatingInterestIncomeExpense109000.095000.0184000.0378000.0397000.0
Operating income-47 M-24 M-25 M-28 M-17 M-26 M-20 M-22 M
Operating income before depreciation (EBITDA)-47 M-24 M-54 M-2 M-15 M-26 M-19 M-22 M
OperatingExpense-48 M-24 M-25 M-28 M17 M26 M20 M22 M
Other income net590000.030 M-25 M-3 M577000.0-605000.0-136000.0
OtherGandA15 M7 M7 M8 M6 M8 M7 M6 M
OtherOperatingExpenses-48 M-24 M-25 M-28 M17 M705000.0707000.0709000.0
RentAndLandingFees15 M7 M7 M8 M600000.0
Research & development expense33 M17 M18 M20 M11 M18 M13 M16 M
ResearchExpense33 M17 M18 M20 M11 M18 M13 M16 M
RestructringAndMnAIncome352000.0
SalariesAndWages-2 M-3 M-3 M-3 M
Selling Gen & administrative expense15 M7 M7 M8 M6 M8 M7 M6 M
Special income/charges-352000.0
Total Income available for interest expense (EBIT)-46 M-24 M-55 M-3 M-15 M-27 M-20 M-22 M
Total common shares outstanding898486.02 M4 M5 M6 M9 M10 M10 M
Total net income-46 M-24 M-55 M3 M-13 M-25 M-18 M-20 M
Total ordinary shares12 M12 M12 M12 M12 M12 M12 M12 M
Total revenues2 M
TotalExpenses-48 M-24 M-25 M-28 M17 M26 M20 M22 M
TotalRevenue2 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University